Literature DB >> 30838802

Image cytometry as an alternative to flow cytometry for the transplant histocompatibility crossmatch assay.

Daniel S Ramon1,2, Thomas Franks2, Andrés Jaramillo1, Benjamin D Paradis3, Leo Li-Ying Chan3.   

Abstract

The lymphocyte crossmatch is currently the only cell-based compatibility assay performed by histocompatibility laboratories for transplant purposes. While in many transplant programs the complement-dependent cytotoxicity crossmatch (CDCXM) remains in use, when available, the flow cytometry crossmatch (FCXM) is the method of choice because of its superior sensitivity and specificity. Unfortunately, the maintenance and cost of a flow cytometer is a considerable limitation for small histocompatibility laboratories. Therefore, in this study, we evaluated the use of the Cellometer Vision CBA image cytometer (Nexcelom Bioscience LLC, Lawrence, Massachusetts) as an alternative instrument to perform the crossmatch assay. The 3-color FCXM protocol was modified into two separate 2-color panel image cytometry crossmatches (IXMs), one for T cells and one for B cells. After initial serum and cell incubation, a cocktail consisting of PE/Cy5-conjugated anti-human CD3 or CD19 and PE-conjugated anti-human IgG F(ab')2 was added to the T cell and B cell panels, respectively. The final cell preparation was added to a separate counting chamber. Images were captured using the Cellometer Vision CBA, an image cytometer designed for cell counting, size analysis and fluorescence intensity measurement. Thirty-nine IXMs were performed and compared with the FCXM. We obtained a concordance sensitivity of 94.1% and 100% and specificity of 100% and 88.9% for T cells and B cells, respectively. The linearity of the system was verified using dilutions of a sample containing known donor-specific anti-HLA antibodies (DSA) against the target cells. This feasibility study demonstrates that the FCXM test could be easily adapted to the Cellometer Vision CBA image cytometer without compromising specificity and sensitivity. The low instrumentation cost, minimal maintenance, and simple operation allow for efficient implementation or transition from the FCXM to the IXM method.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  crossmatch; donor-specific anti-HLA antibodies; flow cytometry; histocompatibility; human leukocyte antigens; image cytometry; transplantation

Mesh:

Substances:

Year:  2019        PMID: 30838802     DOI: 10.1111/tan.13515

Source DB:  PubMed          Journal:  HLA        ISSN: 2059-2302            Impact factor:   4.513


  1 in total

1.  Technical and clinical aspects of the histocompatibility crossmatch assay in solid organ transplantation

Authors:  Ana María Arrunátegui; Daniel S Ramón; Luz Marina Viola; Linda G Olsen; Andrés Jaramillo
Journal:  Biomedica       Date:  2022-06-01       Impact factor: 1.173

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.